Similarly, in tumor, the increased percentage of CD3+, CD4+ or CD8+ T cells was also observed in three treatment groups compared with the control group (each treatment P < 0.05 for each T cell, respectively, n = 6) (Fig. 4). Here, CD8A is linked to neoplasm.